A water-soluble antitumor glycoprotein from Chlorella vulgaris. 1996

K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

An active substance with antitumor activity (ARS2) was purified from the culture media of Chlorella vulgaris and found to be a glycoprotein with a molecular weight of 63,100 amu, as determined by matrix-assisted laser desorption/ ionization (MALDI) mass spectrometry. ARS2 contains 66.9% carbohydrate, mainly D-galactose, and 35.2% protein. The carbohydrate moiety has a beta-1,6-D-galactopyranose backbone, as determined by methylation analysis and 13C-NMR. Apparently, the protein moiety, whose 15 amino acid sequence at the NH2-terminus, we determined as DVGEAFPTVVDALVA, is necessary for the antitumor activity, as assessed by hydrazinolysis, periodate oxidation, and proteolysis.

UI MeSH Term Description Entries
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D002708 Chlorella Nonmotile unicellular green algae potentially valuable as a source of high-grade protein and B-complex vitamins. Chlorellas
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas
D005690 Galactose An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood. D-Galactose,Galactopyranose,Galactopyranoside,D Galactose

Related Publications

K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
September 1987, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
May 1982, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
March 2002, International immunopharmacology,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
February 1998, Cancer immunology, immunotherapy : CII,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
February 2014, Bioresource technology,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
January 1990, Immunopharmacology and immunotoxicology,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
September 2002, Phytotherapy research : PTR,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
January 2016, BioMed research international,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
January 1984, Cancer immunology, immunotherapy : CII,
K Noda, and N Ohno, and K Tanaka, and N Kamiya, and M Okuda, and T Yadomae, and K Nomoto, and Y Shoyama
April 1977, Biochimica et biophysica acta,
Copied contents to your clipboard!